UBS has reaffirmed its 'buy' recommendation on Ontex Group, raising its target price from €10 to €10.7. This new target represents an 18% growth potential for the Belgian personal care products manufacturer.

We continue to see Ontex as an attractive turnaround story", says the broker in his summary note, following the publication of first-quarter 2024 results marked by a further sequential improvement.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.